Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.
Rite Aid's Capital Expenditure for the
three
months ended in Aug. 2023 was $-44.58 Mil. Its Revenue for the
three
months ended in Aug. 2023 was $5,646.08 Mil.
Hence, Rite Aid's Capex-to-Revenue for the
three
months ended in Aug. 2023 was 0.01.
Rite Aid Capex-to-Revenue Historical Data
The historical data trend for Rite Aid's Capex-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Rite Aid's Capex-to-Revenue
For the Pharmaceutical Retailers subindustry, Rite Aid's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rite Aid's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's Capex-to-Revenue distribution charts can be found below:
* The bar in red indicates where Rite Aid's Capex-to-Revenue falls into.
Rite Aid Capex-to-Revenue Calculation
Rite Aid's Capex-to-Revenue for the fiscal year that ended in Feb. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rite Aid (OTCPK:RADCQ) Capex-to-Revenue Explanation
Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.
Rite Aid Capex-to-Revenue Related Terms
Thank you for viewing the detailed overview of Rite Aid's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Rite Aid Corp is a large retail drugstore chain in the United States. The company reports via two segments: retail pharmacy and pharmacy services. The retail pharmacy segment generates revenue primarily through the sale of prescription drugs, along with an assortment of merchandise that includes over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and numerous other everyday consumables. The pharmacy-services segment relates to EnvisionRx, a fully owned subsidiary that operates as a pharmacy benefit management provider offering a broad range of pharmaceutical services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RADCQ has been successfully added to your 